BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 22149840)

  • 1. Dose and dose averaged LET comparison of ¹H, ⁴He, ⁶Li, ⁸Be, ¹⁰B, ¹²C, ¹⁴N, and ¹⁶O ion beams forming a spread-out Bragg peak.
    Kantemiris I; Karaiskos P; Papagiannis P; Angelopoulos A
    Med Phys; 2011 Dec; 38(12):6585-91. PubMed ID: 22149840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LET spectra at different penetration depths along secondary 9C and 11C beams.
    Li Q; Komori M; Kanai T; Kitagawa A; Urakabe E; Kanazawa M; Tomitani T; Sato S
    Phys Med Biol; 2004 Nov; 49(22):5119-33. PubMed ID: 15609562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosimetry of proton and carbon ions.
    Liamsuwan T; Hultqvist M; Lindborg L; Uehara S; Nikjoo H
    Med Phys; 2014 Aug; 41(8):081721. PubMed ID: 25086531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams.
    Kempe J; Gudowska I; Brahme A
    Med Phys; 2007 Jan; 34(1):183-92. PubMed ID: 17278503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
    Grün R; Friedrich T; Traneus E; Scholz M
    Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative biological effectiveness for carbon, nitrogen, and oxygen ion beams using passive and scanning techniques evaluated with fully 3D silicon microdosimeters.
    Tran LT; Bolst D; Guatelli S; Pogossov A; Petasecca M; Lerch MLF; Chartier L; Prokopovich DA; Reinhard MI; Povoli M; Kok A; Perevertaylo VL; Matsufuji N; Kanai T; Jackson M; Rosenfeld AB
    Med Phys; 2018 May; 45(5):2299-2308. PubMed ID: 29572856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of average LET of therapeutic proton beams using Al2O3:C optically stimulated luminescence (OSL) detectors.
    Sawakuchi GO; Sahoo N; Gasparian PB; Rodriguez MG; Archambault L; Titt U; Yukihara EG
    Phys Med Biol; 2010 Sep; 55(17):4963-76. PubMed ID: 20693613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose- rather than fluence-averaged LET should be used as a single-parameter descriptor of proton beam quality for radiochromic film dosimetry.
    Resch AF; Heyes PD; Fuchs H; Bassler N; Georg D; Palmans H
    Med Phys; 2020 Jun; 47(5):2289-2299. PubMed ID: 32166764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric characterization of a microDiamond detector in clinical scanned carbon ion beams.
    Marinelli M; Prestopino G; Verona C; Verona-Rinati G; Ciocca M; Mirandola A; Mairani A; Raffaele L; Magro G
    Med Phys; 2015 Apr; 42(4):2085-93. PubMed ID: 25832098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field-size dependence of doses of therapeutic carbon beams.
    Kusano Y; Kanai T; Yonai S; Komori M; Ikeda N; Tachikawa Y; Ito A; Uchida H
    Med Phys; 2007 Oct; 34(10):4016-22. PubMed ID: 17985647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose- and LET-painting with particle therapy.
    Bassler N; Jäkel O; Søndergaard CS; Petersen JB
    Acta Oncol; 2010 Oct; 49(7):1170-6. PubMed ID: 20831510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Monte Carlo study for the calculation of the average linear energy transfer (LET) distributions for a clinical proton beam line and a radiobiological carbon ion beam line.
    Romano F; Cirrone GA; Cuttone G; Rosa FD; Mazzaglia SE; Petrovic I; Fira AR; Varisano A
    Phys Med Biol; 2014 Jun; 59(12):2863-82. PubMed ID: 24828462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the perturbation effect and LET dependence of beam quality correction factors in carbon ion beams.
    Khan AU; Nelson NP; Culberson WS; DeWerd LA
    Med Phys; 2023 Feb; 50(2):1105-1120. PubMed ID: 36334024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluence correction factors and stopping power ratios for clinical ion beams.
    Lühr A; Hansen DC; Sobolevsky N; Palmans H; Rossomme S; Bassler N
    Acta Oncol; 2011 Aug; 50(6):797-805. PubMed ID: 21767177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the irradiation field of 12C and 16O SOBP beams using positron emitters produced through projectile fragmentation reactions.
    Inaniwa T; Kohno T; Tomitani T; Sato S
    Phys Med Biol; 2008 Feb; 53(3):529-42. PubMed ID: 18199900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo-Based Radiobiological Investigation of the Most Optimal Ion Beam Forming SOBP for Particle Therapy.
    Kantemiris I; Pappas EP; Lymperopoulou G; Thanasas D; Karaiskos P
    J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An initial systematic study of the linear energy transfer distributions of a proton beam under a transverse magnetic field.
    Fujii Y; Ueda H; Umegaki K; Matsuura T
    Med Phys; 2022 Mar; 49(3):1839-1852. PubMed ID: 35124798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles.
    Paganetti H
    Phys Med Biol; 2002 Mar; 47(5):747-64. PubMed ID: 11931469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.